Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, announced that the ECHO Green Pattern Laser photocoagulator has received both FDA 510(k) clearance and CE Mark approval...
The European Union should put in place systems that allow drugmakers to charge higher pricing in wealthy European countries and lower costs in poorer countries to ensure more fair patient access to life-saving medications, according to Bayer's...
Alembic Pharmaceuticals Ltd, an Indian generic drugmaker, announced a nearly seven-fold increase in fourth-quarter profit on Friday, aided by decreased expenses and high revenues from its domestic drug-making sector...
Technologies are revolutionizing the way veterinarians diagnose and treat diseases in animals. Veterinary medicine embraces these technologies to provide more efficient and cost-effective medical care.
Amphista Therapeutics, a pioneer in next-generation targeted protein degradation (TPD) techniques, reported the achievement of the first discovery milestone under its cooperation and licence agreement with Bristol Myers Squibb, triggering...
The approval granted by the US Food and Drug Administration (USFDA) is to manufacture and market Sucralfate Tablets of strength 1 gram, Zydus Lifesciences said in a regulatory filing. The drug will be manufactured at the group's topical...
Bangalore Gastro Centre (BGC), which provides specialised care for various digestive illnesses, has inked a Memorandum of Understanding (MoU) with 3BIGS of South Korea, a worldwide healthcare leader in handling Biodata and artificial intelligence...
Roche Diabetes Care India (RDC India) stated that the 'Accu-Chek Active' blood glucose monitoring device is now manufactured in India. In partnership with their manufacturing partner Sanmina-SCI India and assembly and distribution partner Parekh...
At the International Symposium on Precision Oncology and Personalised Medicine, Kokilaben Dhirubhai Ambani Hospital, a pioneer in introducing the latest medical advancements and cutting-edge technologies in cancer care, the hospital announced the...
AstraZeneca Pharma India Ltd announced on Wednesday that the cancer medicine trastuzumab deruxtecan has been approved by the medicine Controller General of India (DCGI) for the treatment of metastatic breast cancer. The company said that it has....
, CDSCO.jpg)
.jpg)